CN110946817A - 天然草本女士私处专用皮肤黏膜消毒剂 - Google Patents
天然草本女士私处专用皮肤黏膜消毒剂 Download PDFInfo
- Publication number
- CN110946817A CN110946817A CN201811117170.2A CN201811117170A CN110946817A CN 110946817 A CN110946817 A CN 110946817A CN 201811117170 A CN201811117170 A CN 201811117170A CN 110946817 A CN110946817 A CN 110946817A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- oil
- flower
- natural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000645 desinfectant Substances 0.000 title claims abstract description 12
- 210000004877 mucosa Anatomy 0.000 title claims abstract description 12
- 239000000284 extract Substances 0.000 claims abstract description 74
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 21
- 102000016943 Muramidase Human genes 0.000 claims abstract description 17
- 108010014251 Muramidase Proteins 0.000 claims abstract description 17
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims abstract description 17
- 229960000274 lysozyme Drugs 0.000 claims abstract description 17
- 235000010335 lysozyme Nutrition 0.000 claims abstract description 17
- 239000004325 lysozyme Substances 0.000 claims abstract description 17
- 239000003921 oil Substances 0.000 claims abstract description 15
- 235000019198 oils Nutrition 0.000 claims abstract description 15
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 239000001140 aloe barbadensis leaf extract Substances 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 210000000130 stem cell Anatomy 0.000 claims abstract description 14
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 13
- 235000010445 lecithin Nutrition 0.000 claims abstract description 13
- 229940067606 lecithin Drugs 0.000 claims abstract description 13
- 239000000787 lecithin Substances 0.000 claims abstract description 13
- 241000218378 Magnolia Species 0.000 claims abstract description 12
- 239000000341 volatile oil Substances 0.000 claims abstract description 12
- 241000132446 Inula Species 0.000 claims abstract description 11
- 239000004310 lactic acid Substances 0.000 claims abstract description 11
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000019489 Almond oil Nutrition 0.000 claims abstract description 10
- 241001071917 Lithospermum Species 0.000 claims abstract description 10
- 239000008168 almond oil Substances 0.000 claims abstract description 10
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 10
- 229940094952 green tea extract Drugs 0.000 claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims abstract description 9
- 235000011187 glycerol Nutrition 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 9
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims abstract description 8
- 244000042664 Matricaria chamomilla Species 0.000 claims abstract description 8
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims abstract description 8
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract 4
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 2
- 244000181025 Rosa gallica Species 0.000 claims abstract 2
- 241000628997 Flos Species 0.000 claims description 14
- 241000133134 Saussurea Species 0.000 claims description 7
- 239000012071 phase Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 4
- 238000007689 inspection Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 244000144927 Aloe barbadensis Species 0.000 claims description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 2
- 235000011399 aloe vera Nutrition 0.000 claims description 2
- 239000008346 aqueous phase Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000002372 labelling Methods 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 31
- 239000000126 substance Substances 0.000 abstract description 6
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 5
- 208000003251 Pruritus Diseases 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 229940069638 aloe vera leaf extract Drugs 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 240000002853 Nelumbo nucifera Species 0.000 abstract description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract description 2
- 239000002253 acid Substances 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 230000003115 biocidal effect Effects 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract description 2
- 230000007803 itching Effects 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 238000005406 washing Methods 0.000 abstract description 2
- 206010011409 Cross infection Diseases 0.000 abstract 1
- 206010029803 Nosocomial infection Diseases 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 30
- 240000004371 Panax ginseng Species 0.000 description 10
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000004140 cleaning Methods 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 7
- 241001570521 Lonicera periclymenum Species 0.000 description 6
- 230000000474 nursing effect Effects 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 240000004978 Rosa x damascena Species 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000004927 skin cell Anatomy 0.000 description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000000686 essence Substances 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 102000003425 Tyrosinase Human genes 0.000 description 3
- 108060008724 Tyrosinase Proteins 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 108010013639 Peptidoglycan Proteins 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- NEZONWMXZKDMKF-UHFFFAOYSA-N C.I. Natural Red 20 Chemical compound C1=CC(O)=C2C(=O)C(C(O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 241000723422 Catalpa Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 208000022555 Genital disease Diseases 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 240000004035 Lithospermum officinale Species 0.000 description 1
- 235000011030 Lithospermum officinale Nutrition 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 241000007358 Magnolia biondii Species 0.000 description 1
- 240000005819 Magnolia denudata Species 0.000 description 1
- 235000016094 Magnolia denudata Nutrition 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 206010056344 Menstrual discomfort Diseases 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- MNLRQHMNZILYPY-MDMHTWEWSA-N N-acetyl-alpha-D-muramic acid Chemical compound OC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](O)[C@@H]1NC(C)=O MNLRQHMNZILYPY-MDMHTWEWSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- -1 flavonoid compounds Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000010687 lubricating oil Substances 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000009972 noncorrosive effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种天然草本女士私处专用皮肤黏膜消毒剂,配方的有效成份为库拉索芦荟叶提取物、人参干细胞萃取物、绿茶提取物、紫草提取物、杏仁油、洋甘菊精油、天山雪莲花提取物、金银花提取物、旋覆花提取物、玉兰花提取物、突厥蔷薇花油、甘油、卵磷脂、复合溶菌酶、天然乳酸等,经特殊工艺提取、复配而成。本发明的目的提供一种不添加任何化学成分,纯天然草本植物精华和人参干细胞、复合溶菌酶协同作用,使每种有效成分的作用都达到最强的女士私处专用皮肤黏膜消毒剂,不对娇嫩的私处肌肤粘膜造成伤害;利用天然乳酸作为酸碱调节剂,将溶液的pH值调节为适合阴道正常菌群的弱酸性,具有高效杀菌消毒,抗菌抑菌、祛除异味、止痒消炎、避免交叉感染、安全无刺激、无需水洗的特点。
Description
技术领域本发明涉及一种天然草本女士私处专用皮肤黏膜消毒剂,配方的有效成份为库拉索芦荟叶提取物、人参干细胞萃取物、绿茶提取物、紫草提取物、杏仁油、洋甘菊精油、天山雪莲花提取物、金银花提取物、旋覆花提取物、玉兰花提取物、突厥蔷薇花油、甘油、卵磷脂、复合溶菌酶、天然乳酸等,经特殊工艺提取、复配而成。市场上有些护理产品为了达到消毒的效果,往往要加入碱性、酒精等成分,不仅对相对脆弱的皮肤有刺激性,而且会杀灭过多的正常菌群,破坏机体自身的酸性环境,降低自身的自净作用。本发明的目的就是提供一种提取自纯天然草本,不添加任何化学成分的女士私处专用皮肤黏膜消毒剂,特别人参干细胞萃取物和复合溶菌酶的高科技成分等天然杀菌消毒成分,并且利用天然乳酸作为酸碱调节剂,将溶液的pH值调节为适合阴道正常菌群的弱酸性,具有高效杀菌消毒,抗菌抑菌、祛除异味、止痒消炎、避免交叉感染、安全无刺激、无需水洗的特点。
背景技术现今女性都非常重视阴部私处肌肤的清洁、保健,女性的外阴部位需要用特定的外用护理产品进行清洁护理。阴部护理、保养液(剂)等卫生保健用品市场需求不断增大,已成为女性日常最重要的健康用品之一。女性私处护理液主要功效在于调节PH值,清洁,和消毒杀菌。目前市面上的产品大致分为三大类,第一大类是单纯含有营养物质的护理液;第二大类是具有治疗疾病功能的药用洗剂,这种洗剂往往是由多种中草药提取液复配而成,其主要作用是在于治疗各种妇科疾病,起到药用的功效。第三大类是具有清洗和杀菌消毒功能的女性护理液,它的主要成分是表面活性剂和杀菌抗菌剂,用于清洁和杀菌,但同时对机体自身的自净作用有破坏,会降低自身的免疫能力。针对以上问题,本发明采用了库拉索芦荟叶提取物作为溶剂,所有的抗菌成分均来自天然草本生物提取物,水溶性、易挥发、免洗,将清洗,除菌和护理的作用三合一。在达到清洁和除菌目的的同时,最大程度滴降低其成分对机体皮肤的刺激和对生理环境的破坏,同时添加保湿成分,对私处粘膜皮肤起到营养护理作用,并具有抗菌消毒效率高、稳定性好、对环境无污染、有效止痒去味、安全性能高等特点。
发明内容 本发明的要点在于选择合适的组分,使用多种天然草本精华,配合人参干细胞和溶菌酵素酶的协同作用,使每种有效成分的作用都达到最强,最终配伍而成一种天然草本女士私处专用皮肤黏膜消毒剂。
本发明选择的配方如下(组分及其重量百分比%):人参干细胞萃取物1.0-5.0;绿茶提取物2.0-3.0;紫草提取物3.0-5.0;杏仁油1.0-2.0;洋甘菊精油1.0-2.0;天山雪莲花提取物2.0-3.0;金银花提取物2.0-3.0;旋覆花提取物3.0-5.0;玉兰花提取物3.0-5.0;突厥蔷薇花油3.0-5.0;甘油3.0-5.0;卵磷脂1.0-2.0复合溶菌酶0.5-1.0;天然乳酸将pH调至6.8,库拉索芦荟叶提取物加至100。
库拉索芦荟叶提取物植物体中含有库拉索芦荟叶提取物醇、库拉索芦荟叶提取物素、胆碱、有机酸、菊糖等多种健康营养成分。性味甘,微苦,寒。归肝、胃经。有利尿、缓泻、退黄疸、利胆等功效。对金黄色葡萄球菌耐药菌株、溶血性链球菌有较强的杀菌作用。对肺炎双球菌、脑膜炎球菌、白喉杆菌、绿脓杆菌、痢疾杆菌、伤寒杆菌等及卡他球菌也有一定杀菌作用。醇提物能杀死钩端螺旋体,对某些真菌亦有抑制作用。对幽门弯曲杆菌有良好的杀灭作用。
杏仁油由众多杏仁提炼而成,是化妆品中常用的油性原料,天然润滑性好,能迅速被皮肤吸收,无油腻感,可作为气味抑制剂和高级润滑油。由于杏仁油中富含多种维生素等营养物质,所以经常被用于护肤用品。具有预防皱纹和护肤的功效。有巩固皮肤的效用,能减轻神经性皮炎病症的不适,对皮肤出现的红肿、灼热或敏感刺激的状况有冷却、稳定的功效;有极佳的被吸收效果,能迅速地深入至皮肤的角质层内,并锁住水分,而且效果持久。适用全身护肤适合干燥、敏感、娇弱及晒后不适的肌肤,并使肌肤平顺光滑。
绿茶提取物的主要提取成分为茶多酚,是一类存在于茶叶中的多经基酚性化合物,该成分对大肠杆菌、金黄色葡萄球菌、痢疾杆菌及多种致病性皮肤真菌均有明显的抑菌作用;同时因其具有清热燥湿、杀虫的功效,常煎液外用,用于疥癣、麻风、皮肤瘙痒、湿毒疮疡的治疗和预防。能够清除体内的各种自由基,达到抗氧化的效果,其中茶多酚具有收敛性,能够使蛋白质沉淀变性,故具有较强的抗菌作用。
紫草提取物有抗皮肤真菌病毒作用,结合它的抗炎性,皮肤科临床用于治疗扁平疣、银屑病、皮炎、湿疹等;紫草提取物对组织蛋白酶活性有促进作用,表示该提取物可增强皮肤细胞的新陈代谢,结合其抗氧性,有抗衰作用。紫草色素作为天然色素已广泛应用于医药、化妆品工业中。
洋甘菊精油其含挥发油、黄酮类化合物、氨基酸、绿原酸和微量元素等。基于菊花提取物具有抗菌、抗氧化、抗炎、舒缓抗敏等生物活性,广泛应用于化妆品中,可起到预防过敏、保湿、防治粉刺和抗衰老等功效。
人参干细胞萃取物能抑制胶原蛋白的分解,促进胶原蛋白的合成,修复已被紫外线损伤的皮肤细胞,令损伤的细胞再生;帮助形成新的角蛋白细胞,使老化角质层脱落,激活新的皮肤角质细胞;增殖形成维持皮肤弹性的成纤维细胞,使皮肤富有弹性;抑制活性氧的形成,清除活性氧,延缓皮肤细胞的自然老化;能扩张皮肤毛细血管,增加皮肤营养,调节皮肤的水油平衡,保湿抗皱; 抑制黑色素的形成,使皮肤洁白光滑。
天山雪莲花提取物是从天山雪莲花中提取的纯天然产物,能够清除体内自由基,有效延缓黏膜肌肤衰老,同时可以帮助肌肤吸收和锁住水分,长效保湿,避免肌肤干燥粗糙。
金银花为忍冬科植物忍冬的干燥花蕾或带初开的花,味甘,性寒,具有清热解毒、凉散风热之功效。忍冬的花、叶和枝都具有很强的抗氧化和抑制酩氨酸酶的作用,而中花的生物活性最高,具有很高的安全性。
旋覆花为菊科植物旋覆花或欧亚旋覆花的干燥头状花序,味苦、辛、咸,性微温,具有降气、消痰、行水、止呕之功效。旋覆花的水提液除了具有抗氧化和抗突变的作用外,还能够抑制酪氨酸酶的活性,他们通过高效液相色谱法分析旋覆花水提液具有这些生物活性的物质基础可能是含有绿原酸、芦丁、槲皮素、木犀草素和山柰酚。
玉兰花提取物为木兰科植物望春花 、玉兰或武当玉兰的干燥花嚣,味辛,性温,具有散风寒、通鼻窍之功效。玉兰花提取物是这些药材中对黑色素细胞增殖抑制作用最为明显的,抑制率为63.2%,同时可以减少黑色素的生成。玉兰花提取物对酪氨酸酶活性的抑制作用与高浓度的熊果苷相当.证实玉兰的花不仅能够抑制酪氨酸酶的活性,还具有抗氧化的功效。
蔷薇花挥发油可用于香精的调配。对非雄性激素过高而引起的脱发有防治作用;对B-16细胞活性的促进作用,对血管内皮细胞呈增殖活性,可增强血管的强度,可预防皮肤红血丝;对脑酰胺生成的促进作用表明可增加皮脂中脑酰胺的含量,起柔肤作用;对弹性蛋白酶的抑制,反映抗皱的性能,结合具有DOD样活性,可用于抗衰老。
卵磷脂具有乳化、分解油脂的作用。卵磷脂是人体每一个细胞不可缺少的物质,如果缺乏,就会降低皮肤细胞的再生能力,导致皮肤粗糙、有皱纹。如能适当摄取卵磷脂,皮肤再生活力就可以保障,再加上卵磷脂良好的亲水性和亲油性,皮肤当然就有光泽了。
复合溶菌酶可有效杀灭革兰氏阳性菌。溶菌酶结合到细菌表面,减少负电荷并协助对细菌的吞噬作用。溶菌酶进攻细菌细胞壁的组分-肽聚糖,水解连接N-乙酰胞壁酸和N-乙酰葡糖胺第四位碳原子的糖苷键。溶菌酶通过其两个结构域之间的“沟”结合到肽聚糖分子上;随后其底物在酶中形成过渡态的构象。第四个糖扭曲为半椅形构象。在这种扭曲状态(能量较高)中,糖苷键很容易就发生断裂。从而达到杀菌效果。
天然乳酸,可抑制有害菌大肠肝菌、金黄色葡萄球菌、白色念珠菌,平抚瘙痒,祛除异味,并有助于平衡私处肌肤弱酸状态和共栖有益菌群,增加私处肌 肤抗敏、抗炎能力,缓解经期不适,安全呵护无负担。
本发明产品的制备方法是:
(1)制备油相组分:分别将紫草根提取物、杏仁油、洋甘菊精油、天山雪莲花提取物、金银花提取物、旋覆花提取物、玉兰花提取物、突厥蔷薇花油、甘油按比例配制,混合均匀;
(2)制备水相组分:绿茶提取物、人参干细胞萃取物按比例加入库拉索芦荟叶提取物中,溶解搅拌;
(3)将水相组分加热至40℃,缓慢地加入油相组分,乳化均匀;
(4)将上述组分降温至25℃,缓慢加入卵磷脂、复合溶菌酶,搅拌均匀;
(5)用天然乳酸做酸碱调节剂,将溶液pH调至6.0,库拉索芦荟叶提取物至100;
(6)随机抽检,检验合格后,分装入喷瓶,贴标、密封。
本发明具有以下优点:
(1)人参干细胞、复合溶菌酶与天然植物精华协同作用,使每种有效成分的作用都达到最强,不会对娇嫩的私处肌肤粘膜造成伤害;
(2)抗菌消毒效果显著,对细菌、真菌、病毒都有杀灭抑制作用;
(3)有效祛除私处异味,并可以预防生殖器疾病感染;
(4)安全无毒、无刺激、无腐蚀性,对皮肤无损伤、对环境无污染;
(5)使用浓度低、稳定性好、工艺简单,成本低。
具体实施方式 下面结合实施例对本发明作进一步的详细说明:
按照下表所列数据(重量百分比%)及其所述步骤进行配置:
配方一:
人参干细胞萃取物1.0-5.0;绿茶提取物2.0-3.0;紫草提取物3.0-5.0;杏仁油1.0-2.0;洋甘菊精油1.0-2.0;天山雪莲花提取物2.0-3.0;金银花提取物2.0-3.0;旋覆花提取物3.0-5.0;玉兰花提取物3.0-5.0;突厥蔷薇花油3.0-5.0;甘油3.0-5.0;卵磷脂1.0-2.0复合溶菌酶0.5-1.0;天然乳酸 将pH调至6.8,库拉索芦荟叶提取物加至100。
配方二:
人参干细胞萃取物1.0-4.0;绿茶提取物2.5-3.0;紫草提取物4.0-5.0;杏仁油1.5-2.0;洋甘菊精油1.5-2.0;天山雪莲花提取物2.5-3.0;金银花提取物2.5-3.0;旋覆花提取物3.5-5.0;玉兰花提取物3.5-5.0;突厥蔷薇花油4.0-5.0;甘油4.0-5.0;卵磷脂1.5-2.0复合溶菌酶0.6-1.0;天然乳酸 将pH调至6.8,库拉索芦荟叶提取物加至100。
配方三:
人参干细胞萃取物2.0-4.0;绿茶提取物2.2-2.6;紫草提取物4.0-4.5;杏仁油1.2-1.5;洋甘菊精油1.2-1.8;天山雪莲花提取物2.2-2.8;金银花提取物2.2-2.6;旋覆花提取物3.5-4.0;玉兰花提取物3.2-4.5;突厥蔷薇花油3.3-4.7;甘油4.0-4.5;卵磷脂1.3-1.6复合溶菌酶0.6-0.8;天然乳酸 将pH调至6.8,库拉索芦荟叶提取物加至100。
申请人声明,本发明通过上述实施例来说明本发明的工艺方法,但本发明并不局限于上述工艺步骤,即不意味着本发明必须依赖上述工艺步骤才能实施。所属技术领域的技术人员应该明了,对本发明的任何改进,对本发明所选用原料的等效替换及辅助成分的添加、具体方式的选择等,均落在本发明的保护范围和公开范围之内。
Claims (2)
1.一种天然草本女士私处专用皮肤黏膜消毒剂,其特征在于具有如下配方(组分及其重量百分比%):人参干细胞萃取物1.0-5.0;绿茶提取物2.0-3.0;紫草提取物3.0-5.0;杏仁油1.0-2.0;洋甘菊精油1.0-2.0;天山雪莲花提取物2.0-3.0;金银花提取物2.0-3.0;旋覆花提取物3.0-5.0;玉兰花提取物3.0-5.0;突厥蔷薇花油3.0-5.0;甘油3.0-5.0;卵磷脂1.0-2.0;复合溶菌酶0.5-1.0;天然乳酸 将pH调至6.8,库拉索芦荟叶提取物加至100。
2.一种权利要求1所述天然草本女士私处专用皮肤黏膜消毒剂的制备方法,其特征在于具有如下的步骤:
(1)制备油相组分:分别将紫草根提取物、杏仁油、洋甘菊精油、天山雪莲花提取物、金银花提取物、旋覆花提取物、玉兰花提取物、突厥蔷薇花油、甘油按比例配制,混合均匀;
(2)制备水相组分:绿茶提取物、人参干细胞萃取物按比例加入库拉索芦荟叶提取物中,溶解搅拌;
(3)将水相组分加热至40℃,缓慢地加入油相组分,乳化均匀;
(4)将上述组分降温至25℃,缓慢加入卵磷脂、复合溶菌酶,搅拌均匀;
(5)用天然乳酸做酸碱调节剂,将溶液pH调至6.0,库拉索芦荟叶提取物至100;
(6)随机抽检,检验合格后,分装入喷瓶,贴标、密封。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811117170.2A CN110946817A (zh) | 2018-09-25 | 2018-09-25 | 天然草本女士私处专用皮肤黏膜消毒剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811117170.2A CN110946817A (zh) | 2018-09-25 | 2018-09-25 | 天然草本女士私处专用皮肤黏膜消毒剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110946817A true CN110946817A (zh) | 2020-04-03 |
Family
ID=69962213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811117170.2A Pending CN110946817A (zh) | 2018-09-25 | 2018-09-25 | 天然草本女士私处专用皮肤黏膜消毒剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110946817A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2603634A (en) * | 2020-12-21 | 2022-08-10 | Floweressence Cgh Ltd | Flower essence-containing medicaments |
CN115501145A (zh) * | 2022-04-16 | 2022-12-23 | 广州国药健康研究院有限公司 | 一种私密护理液及其制备和使用方法 |
CN116103219A (zh) * | 2022-10-25 | 2023-05-12 | 山东益衡元健康科技有限公司 | 一种雪莲干细胞粉的制备方法及其制得的抑菌剂 |
CN116492268A (zh) * | 2023-06-21 | 2023-07-28 | 潍坊凯利来生物科技有限公司 | 洗手消毒泡腾片及其制备方法 |
-
2018
- 2018-09-25 CN CN201811117170.2A patent/CN110946817A/zh active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2603634A (en) * | 2020-12-21 | 2022-08-10 | Floweressence Cgh Ltd | Flower essence-containing medicaments |
GB2603634B (en) * | 2020-12-21 | 2023-11-15 | Floweressence Cgh Ltd | Flower essence-containing medicaments |
CN115501145A (zh) * | 2022-04-16 | 2022-12-23 | 广州国药健康研究院有限公司 | 一种私密护理液及其制备和使用方法 |
CN116103219A (zh) * | 2022-10-25 | 2023-05-12 | 山东益衡元健康科技有限公司 | 一种雪莲干细胞粉的制备方法及其制得的抑菌剂 |
CN116103219B (zh) * | 2022-10-25 | 2023-07-04 | 山东益衡元健康科技有限公司 | 一种雪莲干细胞粉的制备方法及其制得的抑菌剂 |
CN116492268A (zh) * | 2023-06-21 | 2023-07-28 | 潍坊凯利来生物科技有限公司 | 洗手消毒泡腾片及其制备方法 |
CN116492268B (zh) * | 2023-06-21 | 2023-08-29 | 潍坊凯利来生物科技有限公司 | 洗手消毒泡腾片及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101478945B1 (ko) | 자생 식물 및 천연 한약재 추출물을 함유한 샴푸 조성물 | |
US9511034B1 (en) | Method for applying a skin treatment | |
CN102342993B (zh) | 一种皮肤抗敏修复外用制剂 | |
CN110946817A (zh) | 天然草本女士私处专用皮肤黏膜消毒剂 | |
CN107007515A (zh) | 一种女性私密护理液及其制备方法 | |
KR20190086317A (ko) | 한방 복합추출물을 포함하는 아토피 피부염 예방 또는 개선용 조성물 | |
CN113521164B (zh) | 一种具有抑菌作用的藏药组合物及其制备方法和应用 | |
CN102639099A (zh) | 防脱发和改善头皮的发用化妆品组合物 | |
KR102288724B1 (ko) | 항균, 살균, 항염 및 피부진정 기능의 향상과 피부 면역력의 강화를 위한 기능성 복합 조성물을 함유하는 애완동물용 복합 기능성 샴푸 및 그 제조 방법 | |
KR20200139970A (ko) | 탈모방지 및 발모촉진용 샴푸 및 그 제조방법 | |
CN110946818A (zh) | 天然草本男士私处专用皮肤黏膜消毒剂 | |
CN109106659A (zh) | 一种含有中草药提取物的护肤霜及制备方法 | |
KR102451720B1 (ko) | 피부진정, 피지억제, 가려움 완화 또는 피부보습 효과를 갖는 황금, 로즈마리, 어성초, 사철쑥 및 카렌둘라의 추출물을 함유하는 복합 기능성 조성물을 포함하는 화장료 조성물 및 그 제조 방법 | |
KR102039718B1 (ko) | 여성청결제 및 이의 제조방법 | |
CN113679640A (zh) | 一种天然滋养净肤护肤祛痘洁面凝露及其制备方法 | |
CN112315860A (zh) | 中草药体系婴幼儿护臀膏及其制备方法 | |
KR20220046147A (ko) | 삼채추출물을 이용한 탈모방지 및 발모촉진용 샴푸의 제조방법 | |
CN106344460A (zh) | 一种痤疮肌肤专用保湿祛痘面霜及其制备方法 | |
CN111973523A (zh) | 一种马齿苋抗敏修护面膜及其制备方法 | |
CN107913234B (zh) | 一种鹿茸草牙膏及其制备方法 | |
CN110934784A (zh) | 天然草本婴幼儿专用止痒祛痱水 | |
KR100790808B1 (ko) | 피부 세정제 조성물 | |
CN109431824B (zh) | 一种抗菌除臭凝胶及其应用 | |
KR20190061277A (ko) | 탈모 방지 및 모발을 굵게 할 수 있는 샴푸 조성물 | |
CN108514533A (zh) | 曲酸抑菌洗手液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200403 |
|
WD01 | Invention patent application deemed withdrawn after publication |